Literature DB >> 16148158

Uterine NK cells mediate inflammation-induced fetal demise in IL-10-null mice.

Shaun P Murphy1, Loren D Fast, Nazeeh N Hanna, Surendra Sharma.   

Abstract

Specialized NK cells are recruited in high numbers to the mammalian embryo implantation sites, yet remain pregnancy compatible. It is not well understood whether uterine NK (uNK) cells become adversely activated and mediate fetal demise, a common complication of early pregnancy. In this study we show that mating of IL-10(-/-) mice resulted in fetal resorption or intrauterine growth restriction in response to very low doses of LPS. Pregnancy in congenic wild-type mice was normal even at 10-fold higher LPS doses. Fetal resorption in IL-10(-/-) mice was associated with a significant increase in uNK cell cytotoxic activation and invasion into the placenta. Depletion of uNK cells, TNF-alpha neutralization, or IL-10 administration rescued pregnancy in LPS-treated IL-10(-/-) animals. Our results identify an immune mechanism of fetal demise involving IL-10 deficiency, NK cells, and inflammation. These results may provide insight into adverse pregnancy outcomes in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148158     DOI: 10.4049/jimmunol.175.6.4084

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  88 in total

1.  Relationship between uterine natural killer cells and unexplained repeated miscarriage.

Authors:  Mohamed M Farghali; Abdel-Latif G El-Kholy; Khaled H Swidan; Ibrahim A Abdelazim; Ahmed R Rashed; Ezzat El-Sobky; Mostafa F Goma
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-11-02

2.  Embryo-placento-maternal interaction and biomarkers: from diagnosis to therapy--a workshop report.

Authors:  N G Than; M J Paidas; S Mizutani; S Sharma; J Padbury; E R Barnea
Journal:  Placenta       Date:  2007-03-23       Impact factor: 3.481

Review 3.  NKT cells at the maternal-fetal interface.

Authors:  J E Boyson; I Aktan; D A Barkhuff; A Chant
Journal:  Immunol Invest       Date:  2008       Impact factor: 3.657

Review 4.  Evolution of non-cytotoxic uterine natural killer cells.

Authors:  Satyan Kalkunte; Clinton O Chichester; Francesca Gotsch; Charles L Sentman; Roberto Romero; Surendra Sharma
Journal:  Am J Reprod Immunol       Date:  2008-05       Impact factor: 3.886

5.  Activation of TLR3 in the trophoblast is associated with preterm delivery.

Authors:  Kaori Koga; Ingrid Cardenas; Paulomi Aldo; Vikki M Abrahams; Bing Peng; Sara Fill; Roberto Romero; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2009-03       Impact factor: 3.886

Review 6.  Molecular Regulation of Parturition: The Role of the Decidual Clock.

Authors:  Errol R Norwitz; Elizabeth A Bonney; Victoria V Snegovskikh; Michelle A Williams; Mark Phillippe; Joong Shin Park; Vikki M Abrahams
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-27       Impact factor: 6.915

7.  Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface.

Authors:  Satyan S Kalkunte; Teddy F Mselle; Wendy E Norris; Charles R Wira; Charles L Sentman; Surendra Sharma
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

8.  Resistance to lipopolysaccharide-induced preterm delivery mediated by regulatory T cell function in mice.

Authors:  Peyman Bizargity; Roxana Del Rio; Mark Phillippe; Cory Teuscher; Elizabeth A Bonney
Journal:  Biol Reprod       Date:  2009-01-14       Impact factor: 4.285

9.  NKG2D blockade inhibits poly(I:C)-triggered fetal loss in wild type but not in IL-10-/- mice.

Authors:  Jessica E Thaxton; Tania Nevers; Eliana O Lippe; Sandra M Blois; Shigeru Saito; Surendra Sharma
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

Review 10.  NK cells, autoantibodies, and immunologic infertility: a complex interplay.

Authors:  Caterina De Carolis; Carlo Perricone; Roberto Perricone
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.